Researchers around the world are beginning to test COVID-19 vaccines on younger children.
Pfizer and Moderna are expected to release vaccine test results for children age 12 and over, the Associated Press reports. Pfizer is currently authorized to use its vaccine starting at age 16. Moderna is authorized to vaccinate at age 18.
Johnson & Johnson plans to begin pediatric studies soon.
AstraZeneca in the United Kingdom began a study of its vaccine with 6- to 17-year-olds last month.
Sinovac in China recently submitted preliminary data to Chinese regulators, claiming its vaccine is safe for 3-year-olds.